Post Profile






Study Compares CV Risk Reduction of Statin vs Nonstatin Therapies Used for Lowering LDL-C

In a study appearing in the September 27 issue of JAMA, Marc S. Sabatine, M.D., M.P.H., of Brigham and Women's Hospital, Harvard Medical School, Boston, and colleagues evaluated the association between lowering low-density lipoprotein cholesterol (LDL-C) and relative cardiovascular risk reduction across different statin and nonstatin therapies.
read more

share

Related Posts


Study Examines Link Between Maternal Exposure To Childhood Abuse, Autism Risk

Health : Medical News Today

JAMA Psychiatry Study Highlights A study by Andrea L. Roberts, Ph.D., of the Harvard School of Public Health, Boston, and colleagues suggests that maternal exposure to childhood abuse is associated with an increased risk for autism ...

Drug Helps Control Involuntary, Sudden Movements of Huntington Disease

Health : Newswise Medical News

In a study appearing in the July 5 issue of JAMA, Samuel Frank, M.D., of Harvard Medical School, Boston, and the Huntington Study Group, and colleagues evaluated the efficacy and safety of the drug deutetrabenazine to control a prom...

Physicians' Knowledge About FDA Approval Standards for 'Breakthrough Therapy'

Health : Newswise Medical News

In a study appearing in the April 12 issue of JAMA, Aaron S. Kesselheim, M.D., J.D., M.P.H., of Brigham and Women's Hospital, Boston, and colleagues surveyed internists and specialists to examine their knowledge about Food and Drug ...

Study Suggests Cutaneous Squamous Cell Carcinoma Carries Risk Of Metastasis And Death

Health : Medical News Today

JAMA Dermatology Study Highlights A study by Chrysalyne D. Schmults, M.D., M.S.C.E., of Brigham and Women's Hospital, Boston, and colleagues suggests cutaneous squamous cell carcinoma (CSCC) carries a low but significant risk of met...

Study compares CV risk reduction of statin vs nonstatin therapies used for lowering LDL-C

Diseases & Conditions / Heart Disease : ScienceDaily: Heart Disease

Scientists evaluated the association between lowering low-density lipoprotein cholesterol (LDL-C) and relative cardiovascular risk reduction across different statin and nonstatin therapies.

Comments


Copyright © 2016 Regator, LLC